维普中文期刊产品整合服务
42篇 您的检索式:作者名="Derwinger"
    题名 作者 年代 出处 被引量
1Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer显示文摘AIM: To assess the stage and size of rectal tumours using 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) and three-dimensional (3D) endosonography (ERUS). METHODS: In this study, patients were recruited in a phaseⅠ/Ⅱ trial of neoadjuvant chemotherapy for biopsy-proven rectal cancer planned for surgical resection with or without preoperative radiotherapy. The feasibility and accuracy of 1.5T MRI and 3D ERUS were compared with the histopathology of the fixed surgical specimen (pathology) to determine the stage and size of the rectal cancer before and after neoadjuvant chemotherapy. A Philips Intera 1.5T with a cardiac 5-channel synergy surface coil was used for the MRI, and a B-K Medical Falcon 2101 EXL 3D-Probe was used at 13 MHz for the ERUS. Our hypothesis was that the staging accuracy would be the same when using MRI, ERUS and a combination of MRI and ERUS. For the combination, MRI was chosen for the assessment of the lymph nodes, and ERUS was chosen for the assessment of perirectal tissue penetration. The stage was dichotomised into stageⅠ and stage Ⅱ or greater. The size was measured as the supero-inferior length and the maximal transaxial area of the tumour. RESULTS: The staging feasibility was 37 of 37 for the MRI and 29 of 36 for the ERUS, with stenosis as a limiting factor. Complete sets of investigations were available in 18 patients for size and 23 patients for stage. The stage accuracy by MRI, ERUS and the combination of MRI and ERUS was 0.65, 0.70 and 0.74, respectively, before chemotherapy and 0.65, 0.78 and 0.83, respectively, after chemotherapy. The improvement of the post-chemotherapy staging using the combination of MRI and ERUS compared with the staging using MRI alone was significant (P = 0.046). The post-chemotherapy understaging frequency by MRI, ERUS and the combination of MRI and ERUS was 0.18, 0.14 and 0.045, respectively, and these differences were non-significant. The measurements of the supero-inferior length by ERUS compared with MRI were within 1.96 standard deviations of the difference between the methods (18 mm) for tumours smaller than 50 mm. The agreement with pathology was within 1.96 standard deviations of the difference between imaging and pathology for all tumours with MRI (15 mm) and for tumours that did not exceed 50 mm with ERUS (22 mm). Tumours exceeding 50 mm in length could not be reliably measured by ERUS due to the limit in the length of each recording. CONCLUSION: MRI is preferable to use when assessing the size of large or stenotic rectal tumours. However, staging accuracy is improved by combining MRI with ERUS.Torbjrn Swartling Peter Klebo Kristoffer Derwinger Bengt Gustavsson Gran Kurlberg 2013World Journal of Gastroenterology2013,19,21:9
2A study of lymph node ratio as a prognostic marker in colon cancer显示文摘K. Derwinger G. Carlsson B. Gustavsson 2007European Journal of Surgical Oncology2007,,7:2
3Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal can- cer显示文摘Derwinger kristoffer Kodeda karl Bexe-lindskog elinor 2009Acta Oncologica2009,49,1:1
4Tumourdifferentiation grade is associated with TNM staging and the risk ofnode metastasis in colorectal cancer 显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta Oncol2010,49,1:1
5Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer显示文摘Derwinger K Kodeda K Bexe Lindskog E 2010Acta oncologica2010,49,1:1
6Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta 0ncol2010,49,1:1
7Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer 显示文摘Derwinger K Kodeda K BexeLindskog E 2010Acta Oncologica2010,49,1:1
8Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer 显示文摘Derwinger K Kodeda K 2010Acta Oncologica2010,49,1:1
9Perianal local block for stapled anopexy显示文摘Gerjy R Derwinger K Nystrom PO 2006Dis Colon Rectum2006,49,12:1
10Tumour differentiation grade is associated with TNMstaging and the risk of node metavstasis in colorectal incancer显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta Oncologica2010,49,1:1
11Age aspects of demography, pathology and survivalassessment in colorectal cancer 显示文摘Derwinger K Kodeda K Gerjy R 2010Anticancer Res2010,30,12:1
12A study of the MTHFR gene polymorphism C677T in colorectal cancer显示文摘Derwinger K Wettergren Y Odin E 2009Clin Colorectal Cancer2009,8,1:1
13Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer 显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta Oncol2010,49,1:1
14A study of lymph node ratio as a prognostic marker in colon cancer显示文摘Derwinger K Carlsson G Gustavsson B 2008Eur J Surg Oncol2008,34,7:1
15A study of the MTHFR gene polymorphism C677T in colorectal cancer 显示文摘DERWINGER K WETTERGREN Y ODIN E 2009Clin Colorectal Cancer2009,8,1:1
16Defining stage IU disease in colorectal cancer-aspects on treatment and evaluation of surviv- al显示文摘Derwinger K Carlsson G Ekman T 2010J Surg Oncol2010,102,5:1
17Opening the Window on Comprehensible Pronunciation After 19 Years: A Workplace Training Study显示文摘Tracey M. Derwing Murray J. Munro Jennifer A. Foote Erin Waugh Jason Fleming 2014Language Learning2014,,3:1
18Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta Oncologica2010,49,1:1
19Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer显示文摘Derwinger K Kodeda K Bexe-Lindskog E 2010Acta Oncologica2010,49,1:1
20A study oF lymph node ratio in stage IV colorectal cancer 显示文摘Derwinger K Gustavsson B 2008World J Surg Oncol2008,6,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费